Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in sickle cell disease
NL-OMON23090Not yet recruiting
- Sponsor
- Curama
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of acetylcysteine in sickle cell disease (SCD) (2 arms), sponsored by Curama. Primary endpoint: Effects on laboratory markers. Planned start Oct 2007; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NL-OMON23090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23090.